Top Markets
Coin of the day
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMO
Rank in Stocks #78
Thermo Fisher Scientific Inc. is a global leader in scientific services,... Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Share Price
$607.17
Last synced: 2026-09-09
Market Cap
$225.64B
Change (1 day)
0.53%
Change (1 year)
27.41%
Country
US
Trade Thermo Fisher Scientific Inc. (TMO)

Category

Earnings for Thermo Fisher Scientific Inc. (TMO)
Earnings in Jun 2026 TTM: $7.61B
According to Thermo Fisher Scientific Inc. latest financial reports the company's current earnings are $7.61B. In 2024 the company made an earning of $7.00B, an increase over its 2023 earnings that were of $6.24B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Thermo Fisher Scientific Inc. from 2000 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $7.61B 4.71%
2025 $7.27B 3.89%
2024 $7.00B 12.12%
2023 $6.24B -18.58%
2022 $7.66B -13.29%
2021 $8.84B 22.28%
2020 $7.23B 77.57%
2019 $4.07B 24.77%
2018 $3.26B 34.29%
2017 $2.43B 20.02%
2016 $2.02B 4.52%
2015 $1.94B -7.22%
2014 $2.09B 58.18%
2013 $1.32B 3.95%
2012 $1.27B 12.06%
2011 $1.13B 4.15%
2010 $1.09B 17.32%
2009 $927.10M -19.35%
2008 $1.15B 30.44%
2007 $881.30M 320.93%
2006 $209.37M -26.77%
2005 $285.90M 10.29%
2004 $259.22M 18.56%
2003 $218.63M -24.08%
2002 $287.99M 276.35%
2001 $76.52M -56.09%
2000 $174.26M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$4.76B -37.42%
US
- -
CN
$-252.70M -103.32%
US
$1.61B -78.85%
US
$1.66B -78.21%
US